loader2
Partner With Us NRI

Company details

914.35
955.75
850.00
1,083.15
6M Return 0.47%
1Y Return -2.39%
Mkt Cap.(Cr) 76,546.48
Volume 29,812
Div Yield 0.55%
OI
-
OI Chg %
-
Volume 29,812

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Our Research View

Trading recommendation

Data not found

Investment recommendation

Strong India, US; one-offs hit margins…

Call Date

11 May 2022

Entry Price

910.00

Target Price

1,095.00

Duration

12-18 Month

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 18,326.53 Cr FV: 2.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 20,712.90 -49,208.14
LAST 3M 72,514.10 -86,871.53
LAST 6M 139,386.11 -217,992.74
LAST 12M 232,044.22 -250,830.89

Information

  • About Company
  • Company Info
  • Listing Info
27.98
33.42%
258.2913
11.67%
10.33%
Description
  • Cipla Limited is a pharmaceutical company having a market capitalization of Rs. 73,307.57 crores as of 18th August 2021. The company was incorporated within the year 1935. It reported its consolidated revenue at Rs. 5,504.35 for the quarter ended June 2021. The Bombay Stock Exchange (BSE) and National Stock Exchange have assigned the number 500087 and scrip code CIPLA, respectively. As of 18th August 2021, the shares of Cipla were trading at Rs. 908.85.

    Cipla is headquartered in Mumbai and produces products for various therapeutic areas, including cardiology, children’s health, dermatology & cosmetology, diabetes, HIV/AIDS, infectious illnesses & critical care, malaria, and so on. The drug company primarily develops medicines to treat respiratory, disorders, arthritis, diabetes, weight control and depression, and other medical conditions. Cipla is the third-largest drug company within the country and is present in most countries within the European region, with DTMs in Germany, Norway, UK, and Spain. The company’s promoters hold a 36.72% stake of the total shareholding in the company in June 2021 as against 36.68% in June 2020 with zero pledge. However, the mutual funds holding has also decreased in the last 12 months, decreasing from 16.29% in June 2020 to 13.36% in June 2021, and over the last 3 months, it has decreased 1.28%.

    In June 2021, consolidated total revenue from operations grew 26.64% to Rs. 5,504.35 crores, against Rs. 4,346.16 crores within the corresponding quarter last year. The Indian major pharmaceutical has posted a 23.67% increase in the consolidated net profit of Rs. 714.72 crores, on strong sales performance during June 2021, it had posted a net profit of Rs. 577.91 Crores within the corresponding period of the previous fiscal. EBITDA rose 28% to Rs. 1,346 crores in June 2021, from Rs. 1,049 crores in June 2020. EBITDA margin improved 32 basis points to 24.5%, as against 24.1% in the year-ago period. EPS of the company was Rs. 8.86 as compared to Rs. 5.13 in March 2021. Cipla’s shares closed at 908.85 (NSE) on 18th August 2021 and have returned 18.83% over the last 12 months.

Read More

Registered Address

Cipla House Peninsula Buss Par, Ganpatrao Kadam Mg Lower Parel, Mumbai, Maharashtra, 400013

Tel : 91-22-24826000
Email : cosecretary:cipla.com
Website : http://www.cipla.com

Registrar

Karvy Computershare Pvt Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 2
Market Lot Equity Shares : 1
BSE Code : 500087
NSE Code : CIPLA
Book Closure Date (Month) : Aug
BSE Group : A
ISIN : INE059A01026

ICICIdirect Cipla Ltd FAQ

You can buy Cipla Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Cipla Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Jul 01, 2022 04:01 PM the closing price of Cipla Ltd was ₹ 948.75.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Jul 01, 2022 04:01 PM, the market cap of Cipla Ltd stood at ₹ 76,546.48.
The latest PE ratio of Cipla Ltd as of Jul 01, 2022 04:01 PM is 27.98
The latest PB ratio of Cipla Ltd as of Jul 01, 2022 04:01 PM is 0.28
The 52-week high of Cipla Ltd is ₹ 1,083.15 while the 52-week low is ₹ 850.00 .
According to analyst recommendations, Cipla Ltd has a “Buy” rating for the long term.

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE